(Q37406871)

20 August 2017

1 reference

title

Cardiovascular clinical trials in Japan and controversies regarding prospective randomized open-label blinded end-point design (English)

1 reference

20 August 2017

1 reference

Takahide Kohro

1

1 reference

20 August 2017

Tsutomu Yamazaki

series ordinal

2

1 reference

20 August 2017

publication date

16 January 2009

1 reference

20 August 2017

published in

Hypertension Research

1 reference

20 August 2017

volume

32

1 reference

20 August 2017

issue

2

1 reference

20 August 2017

page(s)

109-114

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2008.26

20 August 2017

exact match

0 references

cites work

Proposed new score to rate the strength of evidence and its application to large-scale clinical trials of angiotensin-receptor blockers

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

Referral from secondary care and to aftercare in a tertiary care university hospital in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

Long-term survival after cardiac surgery is predicted by estimated glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

Idraparinux versus standard therapy for venous thromboembolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction; the LoWASA Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

Sum and substance in the Jikei Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

7 January 2021

Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

7 January 2021

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

7 January 2021

https://api.crossref.org/works/10.1038%2FHR.2008.26

1 reference

7 January 2021

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

7 January 2021

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

7 January 2021

Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FHR.2008.26

7 January 2021

Identifiers

DOI

10.1038/HR.2008.26

1 reference

20 August 2017

1 reference